PATENT CLAIM ANALYSIS

Application Number: 16096830
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-05
Patent Classification: ["548", "950000"]

Abstract:
Pharmaceutical compositions of the invention comprise compounds, compositions, methods useful for the treatment of drug addiction, drug withdrawal, and diseases or conditions that involve dysregulation of glutamate homeostasis in its etiology.

Claim (Index 38):
The method according to  claim 37 , wherein the at least one compound is administered in a composition further comprising at least one excipient.

Metadata:
- Claim Count in Document: 107.0
- Percentile: 97.0
- Lexical Diversity: 1.28571
- Patent Class: 548.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14895681', '14781081', '14388175', '15873293', '14412050']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6990432758531165
- 35 USC 102 Novelty (BERT): 0.5515487753454514
- Combined Prediction Score: 0.6842938258023501
- Mean Citation Score: 304.931952
- Max Citation Score: 425.56122
- Similarity Product: 274.1647364194393

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test